Recent News

• 11.12.2025 - Collegium to Participate in Upcoming Investor Conferences
• 11.06.2025 - Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
• 10.29.2025 - Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
• 10.23.2025 - Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
• 10.22.2025 - Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
• 10.13.2025 - Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference

Recent Filings

• 11.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.12.2025 - 144 Report of proposed sale of securities
• 11.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.06.2025 - EX-99.1 EX-99.1
• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.06.2025 - 144 Report of proposed sale of securities
• 11.06.2025 - 8-K Current report
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.29.2025 - 144 Report of proposed sale of securities